{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:41:32Z","timestamp":1794408092690,"version":"4.9.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":178,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.nicl.2021.102750","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T04:05:16Z","timestamp":1625112316000},"page":"102750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Evaluation of the early-phase [18F]AV45 PET as an optimal surrogate of [18F]FDG PET in ageing and Alzheimer\u2019s clinical syndrome"],"prefix":"10.1016","volume":"31","author":[{"given":"Matthieu","family":"Vanhoutte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Landeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siya","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"de la Sayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dautricourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Chocat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Ch\u00e9telat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2021.102750_b0005","article-title":"Dual-phase [18F]florbetapir in frontotemporal dementia","author":"Asghar","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol Imaging"},{"key":"10.1016\/j.nicl.2021.102750_b0010","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1523\/JNEUROSCI.0150-15.2015","article-title":"Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer\u2019s disease","volume":"35","author":"Besson","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nicl.2021.102750_b0015","doi-asserted-by":"crossref","unstructured":"Bilgel, M., Beason-Held, L., An, Y., Zhou, Y., Wong, D.F., Resnick, S.M., 2019. Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging. J. Cereb. Blood Flow Metab. 0271678X19830537. https:\/\/doi.org\/10\/gfvphq.","DOI":"10.1177\/0271678X19830537"},{"key":"10.1016\/j.nicl.2021.102750_b0020","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2967\/jnumed.117.200964","article-title":"Validation of noninvasive tracer kinetic analysis of 18F-Florbetaben PET using a dual\u2013time-window acquisition protocol","volume":"59","author":"Bullich","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2021.102750_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid and FDG-PET in the diagnostic work-up of Alzheimer\u2019s disease and other dementias","author":"Ch\u00e9telat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nicl.2021.102750_b0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WAD.0b013e31821300bc","article-title":"Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With A\u03b2 Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue: Alzheimer Dis","volume":"26","author":"Choi","year":"2012","journal-title":"Assoc. Disord."},{"key":"10.1016\/j.nicl.2021.102750_b0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neuroimage.2012.09.050","article-title":"Cortical thickness and central surface estimation","volume":"65","author":"Dahnke","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2021.102750_b0040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jalz.2017.02.009","article-title":"Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials","volume":"13","author":"Fleisher","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2021.102750_b0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbadis.2011.11.006","article-title":"The use of PIB-PET as a dual pathological and functional biomarker in AD","volume":"1822","author":"Forsberg","year":"2012","journal-title":"Biochim. Biophys. Acta BBA-Mol. Basis Dis."},{"key":"10.1016\/j.nicl.2021.102750_b0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/nimg.1996.0074","article-title":"Detecting activations in PET and fMRI: levels of inference and power","volume":"4","author":"Friston","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2021.102750_b0055","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s00330-014-3311-x","article-title":"Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis","volume":"24","author":"Fu","year":"2014","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.nicl.2021.102750_b0060","doi-asserted-by":"crossref","unstructured":"Gonneaud, J., Arenaza-Urquijo, E.M., M\u00e9zenge, F., Landeau, B., Gaubert, M., Bejanin, A., de Flores, R., Wirth, M., Tomadesso, C., Poisnel, G., Abbas, A., Desgranges, B., Ch\u00e9telat, G., 2017. Increased florbetapir binding in the temporal neocortex from age 20 to 60 years. Neurology 89, 2438\u20132446. https:\/\/doi.org\/10\/gcxw5t.","DOI":"10.1212\/WNL.0000000000004733"},{"key":"10.1016\/j.nicl.2021.102750_b0065","doi-asserted-by":"crossref","unstructured":"Gonzalez-Escamilla, G., Lange, C., Teipel, S., Buchert, R., Grothe, M.J., 2017. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET \u2013 Application to amyloid imaging with AV45-PET. NeuroImage 147, 669\u2013677. https:\/\/doi.org\/10\/f9xdcm.","DOI":"10.1016\/j.neuroimage.2016.12.077"},{"key":"10.1016\/j.nicl.2021.102750_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","article-title":"Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data","volume":"92","author":"Greve","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2021.102750_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/87565648709540361","article-title":"Genuine memory deficits in dementia","volume":"3","author":"Grober","year":"1987","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.nicl.2021.102750_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/cercor\/bhn087","article-title":"Regional differences in the coupling between resting cerebral blood flow and metabolism may indicate action preparedness as a default state","volume":"19","author":"Gur","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nicl.2021.102750_b0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hbm.10123","article-title":"Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe","volume":"19","author":"Hammers","year":"2003","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nicl.2021.102750_b0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/nimg.2002.1208","article-title":"Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET","volume":"17","author":"Herholz","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2021.102750_b0095","series-title":"Nonparametric Statistical Methods","author":"Hollander","year":"2013"},{"key":"10.1016\/j.nicl.2021.102750_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004647-199601000-00002","article-title":"Nonparametric analysis of statistic images from functional mapping experiments","volume":"16","author":"Holmes","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nicl.2021.102750_b0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-011-2051-2","article-title":"Correlation of early-phase 18 F-florbetapir (AV-45\/Amyvid) PET images to FDG images: preliminary studies","volume":"39","author":"Hsiao","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2021.102750_b0110","doi-asserted-by":"crossref","unstructured":"Jack, C.R., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., Holtzman, D.M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J.L., Montine, T., Phelps, C., Rankin, K.P., Rowe, C.C., Scheltens, P., Siemers, E., Snyder, H.M., Sperling, R., Elliott, C., Masliah, E., Ryan, L., Silverberg, N., 2018. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562. DOI:10\/gdhffb.","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"10.1016\/j.nicl.2021.102750_b0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2021.102750_b0120","article-title":"Utility of perfusion PET measures to assess neuronal injury in Alzheimer\u2019s disease","author":"Joseph-Mathurin","year":"2018","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.nicl.2021.102750_b0125","doi-asserted-by":"crossref","unstructured":"Kuo, H.-C., Hsiao, I.-T., Hsieh, C.-J., Huang, C.-Y., Huang, K.-L., Wai, Y.-Y., Chuang, W.-L., Kung, M.-P., Chu, Y.-C., Yen, T.-C., Lin, K.-J., Huang, C.-C., 2017. Dual-phase 18F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer\u2019s disease, and healthy controls: A preliminary study. J. Formos. Med. Assoc. 116, 964\u2013972. DOI:10\/gfvxsd.","DOI":"10.1016\/j.jfma.2017.03.003"},{"key":"10.1016\/j.nicl.2021.102750_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nicl.2013.08.007","article-title":"Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer\u2019s disease and semantic dementia","volume":"3","author":"La Joie","year":"2013","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.nicl.2021.102750_b0135","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jalz.2018.06.2855","article-title":"Molecular imaging in dementia: past, present, and future","volume":"14","author":"Laforce","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2021.102750_b0140","doi-asserted-by":"crossref","unstructured":"Landau, S.M., Fero, A., Baker, S.L., Koeppe, R., Mintun, M., Chen, K., Reiman, E.M., Jagust, W.J., 2015. Measurement of Longitudinal \u03b2-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios. J. Nucl. Med. Off. Publ. Soc. Nucl. Med. 56, 567\u2013574. DOI:10\/f66mpq.","DOI":"10.2967\/jnumed.114.148981"},{"key":"10.1016\/j.nicl.2021.102750_b0145","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2021.102750_b0150","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","article-title":"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"35","author":"Li","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2021.102750_b0155","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00259-016-3359-8","article-title":"Imaging characteristic of dual-phase 18 F-florbetapir (AV-45\/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer\u2019s disease and mild cognitive impairment","volume":"43","author":"Lin","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2021.102750_b0160","article-title":"Differentiating between Normal Aging, Mild Cognitive Impairment, and Alzheimer\u2019s disease with FDG-PET: Effects of Normalization Region and Partial Volume Correction Method","volume":"03","author":"M Bauer","year":"2013","journal-title":"J. Alzheimers Dis. Park."},{"key":"10.1016\/j.nicl.2021.102750_b0165","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","article-title":"An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets","volume":"19","author":"Maldjian","year":"2003","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2021.102750_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fninf.2018.00094","article-title":"An Automated Pipeline for the Analysis of PET Data on the Cortical Surface","volume":"12","author":"Marcoux","year":"2018","journal-title":"Front. Neuroinformatics"},{"key":"10.1016\/j.nicl.2021.102750_b0175","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2021.102750_b0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nicl.2021.102750_b0185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004728-199507000-00006","article-title":"Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis","volume":"19","author":"Minoshima","year":"1995","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.nicl.2021.102750_b0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-2010-091504","article-title":"Pre-clinical detection of Alzheimer\u2019s disease using FDG-PET, with or without amyloid imaging","volume":"20","author":"Mosconi","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2021.102750_b0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","article-title":"Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects","volume":"12","author":"Muller-Gartner","year":"1992","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nicl.2021.102750_b0200","doi-asserted-by":"crossref","unstructured":"Mutlu, J., Landeau, B., Gaubert, M., de La Sayette, V., Desgranges, B., Ch\u00e9telat, G., 2017. Distinct influence of specific versus global connectivity on the different Alzheimer\u2019s disease biomarkers. Brain 140, 3317\u20133328. DOI:10\/gf5f7s.","DOI":"10.1093\/brain\/awx279"},{"key":"10.1016\/j.nicl.2021.102750_b0205","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jalz.2012.07.003","article-title":"Impact of molecular imaging on the diagnostic process in a memory clinic","volume":"9","author":"Ossenkoppele","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2021.102750_b0210","doi-asserted-by":"crossref","unstructured":"Ottoy, J., Verhaeghe, J., Niemantsverdriet, E., De Roeck, E., wyffels, L., Ceyssens, S., Van Broeckhoven, C., Engelborghs, S., Stroobants, S., Staelens, S., 2019. 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer\u2019s disease: Validation against 15O-H2O PET. Alzheimers Dement. DOI:10\/gf6nnk.","DOI":"10.1016\/j.jalz.2019.05.010"},{"key":"10.1016\/j.nicl.2021.102750_b0215","doi-asserted-by":"crossref","unstructured":"Paulson, O.B., Hasselbalch, S.G., Rostrup, E., Knudsen, G.M., Pelligrino, D., 2010. Cerebral blood flow response to functional activation. J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 30, 2\u201314. DOI:10\/b6mzv5.","DOI":"10.1038\/jcbfm.2009.188"},{"key":"10.1016\/j.nicl.2021.102750_b0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nicl.2014.10.009","article-title":"Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting","volume":"6","author":"Perani","year":"2014","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.nicl.2021.102750_b0225","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archneur.62.7.1160","article-title":"Mild cognitive impairment as a clinical entity and treatment target","volume":"62","author":"Petersen","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2021.102750_b0230","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.trci.2018.10.011","article-title":"The Age-Well randomized controlled trial of the Medit-Ageing European project: effect of meditation or foreign language training on brain and mental health in older adults","volume":"4","author":"Poisnel","year":"2018","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.nicl.2021.102750_b0235","article-title":"Neuropredict: easy machine learning and standardized predictive analysis of biomarkers","author":"Raamana","year":"2017","journal-title":"Zenodo"},{"key":"10.1016\/j.nicl.2021.102750_b0240","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.115.168732","article-title":"Comparison of early phase 11C-deuterium-L-deprenyl and 11C-PiB PET for assessing brain perfusion in Alzheimer\u2019s disease","author":"Rodriguez-Vieitez","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2021.102750_b0245","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/0271678X16645593","article-title":"Comparability of [18F] THK5317 and [11C] PIB blood flow proxy images with [18F] FDG positron emission tomography in Alzheimer\u2019s disease","volume":"37","author":"Rodriguez-Vieitez","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nicl.2021.102750_b0250","first-page":"173","article-title":"Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable; A Study validated in a Cohort of AD and FTLD","volume":"52","author":"Rostomian","year":"2011","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.nicl.2021.102750_b0255","first-page":"1","article-title":"Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study","author":"Segovia","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2021.102750_b0260","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/bpa.12399","article-title":"Longitudinal Positron Emission Tomography in Preventive Alzheimer\u2019s Disease Drug Trials, Critical Barriers from Imaging Science Perspective: Longitudinal PET studies in AD","volume":"26","author":"Shokouhi","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nicl.2021.102750_b0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-016-0172-3","article-title":"Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment","volume":"8","author":"Shokouhi","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nicl.2021.102750_b0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroimage.2008.03.061","article-title":"Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference","volume":"44","author":"Smith","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2021.102750_b0275","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1474-4422(15)00093-9","article-title":"Multimodal imaging in Alzheimer\u2019s disease: validity and usefulness for early detection","volume":"14","author":"Teipel","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nicl.2021.102750_b0280","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00259-016-3393-6","article-title":"Dual-phase amyloid PET: hitting two birds with one stone","volume":"43","author":"Valentina","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2021.102750_b0285","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","article-title":"Permutation inference for the general linear model","volume":"92","author":"Winkler","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2021.102750_b0290","doi-asserted-by":"crossref","unstructured":"Wirth, M., Bejanin, A., La Joie, R., Arenaza-Urquijo, E.M., Gonneaud, J., Landeau, B., Perrotin, A., M\u00e9zenge, F., de La Sayette, V., Desgranges, B., Ch\u00e9telat, G., 2018. Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer\u2019s disease. Neurobiol. Aging 63, 140\u2013151. DOI:10\/gf5f22.","DOI":"10.1016\/j.neurobiolaging.2017.10.023"},{"key":"10.1016\/j.nicl.2021.102750_b0295","doi-asserted-by":"crossref","unstructured":"Wong, D.F., Rosenberg, P.B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H.T., Dannals, R.F., Nandi, A., Bra\u0161i\u0107, J.R., Ye, W., Hilton, J., Lyketsos, C., Kung, H.F., Joshi, A.D., Skovronsky, D.M., Pontecorvo, M.J., 2010. In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18). J. Nucl. Med. 51, 913\u2013920. DOI:10\/dft6pq.","DOI":"10.2967\/jnumed.109.069088"},{"key":"10.1016\/j.nicl.2021.102750_b0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pscychresns.2007.11.004","article-title":"Choice of reference area in studies of Alzheimer\u2019s disease using positron emission tomography with fluorodeoxyglucose-F18","volume":"164","author":"Yakushev","year":"2008","journal-title":"Psychiatry Res."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158221001947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158221001947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:41:47Z","timestamp":1761972107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158221001947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":60,"alternative-id":["S2213158221001947"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2021.102750","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the early-phase [18F]AV45 PET as an optimal surrogate of [18F]FDG PET in ageing and Alzheimer\u2019s clinical syndrome","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2021.102750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102750"}}